Rachael Anforth - Publications, H-index & Citations

Rachael Anforth

NSW Health

14H指数

36论文数

1.1K被引数

收录论文 11

发表时间

Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma

JOURNAL OF IMMUNOTHERAPY

IF2.9

2018-09-01

PREAI

Zhao, Cathy Yunjia; Hwang, Shelley Ji Eun; Anforth, Rachael; Carlos, Giuliana; Chou, Shaun; Carlino, Matteo; Fernandez-Penas, Pablo

Mechanisms of BRAFi-induced hyperproliferative cutaneous conditions

EXPERIMENTAL DERMATOLOGY

IF3.1

2016-05-11

OAAI

Ali, Marina; Anforth, Rachael; Senetiner, Flavia; Carlos, Giuliana; Fernandez-Penas, Pablo

Treatment-specific utility weightings are needed for cost-utility analysis in metastatic melanoma

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2016-01-09

PREAI

Sebaratnam, D. F.; Anforth, R.; Fernandez-Penas, P.

Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors forMetastatic Melanoma

JAMA DERMATOLOGY

IF11

2015-10-01

113

OAAI

Carlos, Giuliana; Anforth, Rachael; Clements, Arthur; Menzies, Alexander M.; Carlino, Matteo S.; Chou, Shaun; Fernandez-Penas, Pablo

Tinea hidden by a vemurafenib-induced phototoxic reaction in a patient with metastatic melanoma taking dexamethasone

MEDICAL JOURNAL OF AUSTRALIA

IF8.5

2015-07-06

PREAI

Anforth, Rachael; Carlos, Giuliana; Eiris, Noemi; Clements, Arthur; Fernandez-Penas, Pablo

Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

IF11.8

2015-05-01

PREAI

Anforth, Rachael; Menzies, Alexander; Byth, Karen; Carlos, Giuliana; Chou, Shaun; Sharma, Raghwa; Scolyer, Richard A.; Kefford, Richard; Long, Georgina V.; Fernandez-Penas, Pablo

Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2014-11-21

OAAI

Anforth, R.; Carlos, G.; Clements, A.; Kefford, R.; Fernandez-Penas, P.

Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2013-12-02

PREAI

Anforth, R.; Blumetti, T. C. M. P.; Clements, A.; Kefford, R.; Long, G. V.; Fernandez-Penas, P.

Non-evolving linear facial plaque

CLINICAL AND EXPERIMENTAL DERMATOLOGY

IF2.8

2013-04-12

PREAI

Affandi, A. Mohd; Anforth, R.; Chou, S.; Fernadez-Penas, P.

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

BRITISH JOURNAL OF DERMATOLOGY

IF9.6

2012-10-05

148

PREAI

Anforth, R. M.; Blumetti, T. C. M. P.; Kefford, R. F.; Sharma, R.; Scolyer, R. A.; Kossard, S.; Long, G. V.; Fernandez-Penas, P.

Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking BRAF inhibitors 服用BRAF抑制剂的患者皮肤鳞状细胞癌和疣状角化病的突变分析

PIGMENT CELL & MELANOMA RESEARCH

IF2.6

2012-08-06

OAAI

Anforth, Rachael; Tembe, Varsha; Blumetti, Tatiana; Fernandez-Penas, Pablo

研究方向